Year archive

HLS Therapeutics Inc. — 2024 filings

All 16 regulatory filings released by HLS Therapeutics Inc. (HLS) in 2024, sourced directly from the official regulator.

16 Filings

2024 Period

2024 filings (16)

Filing	Released	Lang
News release - English.pdf Call Transcript	2024-10-24	English
News release - English.pdf Call Transcript	2024-07-25	English
News release - English.pdf Capital/Financing Update	2024-07-02	English
Management information circular - English.pdf Regulatory Filings	2024-05-17	English
Form of proxy - English.pdf AGM Information	2024-05-17	English
Audited annual financial statements (amended) - English.pdf Audit Report / Information	2024-04-12	English
News release - English.pdf Investor Presentation	2024-04-08	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-03-14	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-03-14	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-03-14	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-03-14	English
Annual information form - English.pdf Annual Report	2024-03-14	English
Annual MD&A - English.pdf Management Reports	2024-03-14	English
Audited annual financial statements – English.pdf Audit Report / Information	2024-03-14	English
News release - English.pdf Annual Report	2024-03-14	English
News release - English.pdf Capital/Financing Update	2024-02-06	English